يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"American Society of ClinicalOncology (ASCO)2023"', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    مؤتمر
    Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.

    المؤلفون: Raghav, Kanwal Pratap Singh, Siena, Salvatore, Takashima, Atsuo, Kato, Takeshi, Van den Eynde, Marc, Di Bartolomeo, Maria, Komatsu, Yoshito, Kawakami, Hisato, Peeters, Marc, Andre, Thierry, Lonardi, Sara, Yamaguchi, Kensei, Tie, Jeanne, Gravalos Castro, Cristina, Strickler, John H, Barrios, Daniel, Yan, Qi, Kamio, Takahiro, Kobayashi, Kojiro, Yoshino, Takayuki, American Society of ClinicalOncology (ASCO)2023

    المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service d'hépato-gastro-entérologie, UCL - (SLuc) Service d'oncologie médicale

    المصدر: Journal of Clinical Oncology, Vol. 41, no.16_suppl, p. 3501-3501 (2023)

    مصطلحات موضوعية: Cancer Research, Oncology

    العلاقة: boreal:277898; http://hdl.handle.net/2078.1/277898Test; urn:ISSN:0732-183X; urn:EISSN:1527-7755

    الإتاحة: https://doi.org/10.1200/jcoTest.2023.41.16_suppl.3501
    http://hdl.handle.net/2078.1/277898Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    مؤتمر
    Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.

    المؤلفون: Raghav, Kanwal Pratap Singh, Siena, Salvatore, Takashima, Atsuo, Kato, Takeshi, Van den Eynde, Marc, Di Bartolomeo, Maria, Komatsu, Yoshito, Kawakami, Hisato, Peeters, Marc, Andre, Thierry, Lonardi, Sara, Yamaguchi, Kensei, Tie, Jeanne, Gravalos Castro, Cristina, Strickler, John H, Barrios, Daniel, Yan, Qi, Kamio, Takahiro, Kobayashi, Kojiro, Yoshino, Takayuki, American Society of ClinicalOncology (ASCO)2023

    المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service d'hépato-gastro-entérologie, UCL - (SLuc) Service d'oncologie médicale

    المصدر: Journal of Clinical Oncology, Vol. 41, no.16_suppl, p. 3501-3501 (2023)

    مصطلحات موضوعية: Cancer Research, Oncology

    العلاقة: boreal:277898; http://hdl.handle.net/2078.1/277898Test; urn:ISSN:0732-183X; urn:EISSN:1527-7755

    الإتاحة: https://doi.org/10.1200/jcoTest.2023.41.16_suppl.3501
    http://hdl.handle.net/2078.1/277898Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث